Alison Edelman

Pharmacogenomics of an Ovulation Modulator and the Impact on Delay of Ovulation

National Institute of Child Health and Human Development · R01

Contact PI · $4.1M · Oregon Health & Science University

A Phase 2b Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception

National Institute of Child Health and Human Development · N01

Contact PI · $619.5K · Columbia University Health Sciences

Cctn-Pharmacokinetic / Pharmacodynamic Evaluation of Levonorgestrel Butanoate for Female Contraception - Oregon

National Institute of Child Health and Human Development · N01

Contact PI · $685K · Oregon Health & Science University

Determining the Impact of COVID-19 Vaccination on the Menstrual Cycle

National Institute of Child Health and Human Development · R01

Contact PI · $1.7M · Oregon Health & Science University

Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects

Principal investigator · Completed · Phase 4

Oregon Health and Science University

Endometrial Biopsy in Progestin Contraceptive Users

Principal investigator · Recruiting · Early phase 1

Oregon Health and Science University

Disparities in Emergency Contraceptive Metabolism Dictate Efficacy

Principal investigator · Recruiting · Phase 4

Oregon Health and Science University

Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill

Principal investigator · Completed · Phase 2

HRA Pharma